Buyer Information
Order Summary
| Report | Global Drugs for HR+/HER2- Advanced Breast Cancer Market Growth 2025-2031 |
| Selected License | Multi ID: LPI39790 |
Total Amount: $5490.00
| Report | Global Drugs for HR+/HER2- Advanced Breast Cancer Market Growth 2025-2031 |
| Selected License | Multi ID: LPI39790 |